000			01723nam a2200349Ia 4500
001			112201
003			BIBL
005			20160527183328.0
008			920225s1992 dcua b f000 0 eng d
020			_a0160372275
035			_a(OCoLC)25330752
040			_aFTC _cFTC _dGPO _dOCL _dTJM
043			_an-us---
049			_aBDDF
074			_a1016-A, 1016-B (MF)
086	0		_aY 4.G 74/7:An 8/7
090			_aRM345 _b.U5H8 1991
110	1	0	_aUnited States _bCongress. _bHouse. _bCommittee on Government Operations. _bHuman Resources and Intergovernmental Relations Subcommittee. _9182913 _2Local
245	1	0	_aProblems with FDA's regulation of the antiarrhythmic drugs Tambocor and Enkaid _bhearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, first session, April 10, 1991.
260	0		_aWashington _bU.S. G.P.O. _bFor sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office _c1992.
300			_aiii, 327 p. _bill. _c24 cm.
500			_aDistributed to some depository libraries in microfiche.
500			_aShipping list no.: 92-111-P.
504			_aIncludes bibliographical references.
610	1	0	_aUnited States _bFood and Drug Administration. _9182913 _2Local
650		0	_aCardiovascular agents. _zUnited States. _969203 _2Local
650		2	_aLegislation, Drug _zUnited States. _9124571 _2Local
650		2	_aAnti-Arrhythmia Agents _xstandards _9196349 _2Local
650		2	_aAnti-Arrhythmia Agents _xadverse effects _9196349 _2Local
650		0	_aDrugs _xAdministration _xGovernment policy _zUnited States. _988821 _2Local
650		0	_aArrhythmia _xTreatment _zUnited States. _954761 _2Local
999			_c93682 _d93682